These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26281086)

  • 1. [CANNABIS AND GLAUCOMA: AN ANCIENT LEGEND OR A NOVEL THERAPEUTIC HORIZON?].
    Mathalone N; Wolf A; Geyer O
    Harefuah; 2015 Jun; 154(6):394-7, 403. PubMed ID: 26281086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing vision loss from glaucoma: putting data from clinical trials into practice.
    Schoenleber DB
    Mo Med; 2005; 102(1):51-4. PubMed ID: 15754618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.
    Merritt JC; Perry DD; Russell DN; Jones BF
    J Clin Pharmacol; 1981; 21(S1):467S-471S. PubMed ID: 6271841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.
    ElSohly MA; Harland EC; Benigni DA; Waller CW
    Curr Eye Res; 1984 Jun; 3(6):841-50. PubMed ID: 6329602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diphenylhydantoin on glaucomatous field loss: a preliminary report.
    Becker B; Stamper RL; Asseff C; Podos SM
    Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(2):412-22. PubMed ID: 4270306
    [No Abstract]   [Full Text] [Related]  

  • 6. Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve.
    Mahmoud SS; ElAbrak ES; Aly MA; Ali EM
    PLoS One; 2019; 14(2):e0212588. PubMed ID: 30789966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
    Merritt JC; Olsen JL; Armstrong JR; McKinnon SM
    J Pharm Pharmacol; 1981 Jan; 33(1):40-1. PubMed ID: 6114151
    [No Abstract]   [Full Text] [Related]  

  • 9. The medical management of primary open-angle glaucoma in the elderly patient.
    Schoevaerdts D; Levecq L; Vanpee D; Swine C
    Z Gerontol Geriatr; 2003 Apr; 36(2):121-3. PubMed ID: 12720024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of delta-9-tetrahydrocannabinol on ophthalmotonus].
    Cuendet JF; Shapiro D; Calanca A; Faggioni R; Ducrey N
    Ophthalmologica; 1976; 172(2-3):122-7. PubMed ID: 1256748
    [No Abstract]   [Full Text] [Related]  

  • 11. Current and emerging medical therapies in the treatment of glaucoma.
    Bagnis A; Papadia M; Scotto R; Traverso CE
    Expert Opin Emerg Drugs; 2011 Jun; 16(2):293-307. PubMed ID: 21406029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sturge-Weber syndrome and glaucoma.
    Basler L; Sowka J
    Optometry; 2011 May; 82(5):306-9. PubMed ID: 21524602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiological approach to glaucoma management: the use of local hormones and the pharmacokinetics of prostaglandin esters.
    Bito LZ
    Prog Clin Biol Res; 1989; 312():329-47. PubMed ID: 2572000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cupping of the optic disc with compressive lesions of the anterior visual pathway.
    Kupersmith MJ; Krohn D
    Ann Ophthalmol; 1984 Oct; 16(10):948-53. PubMed ID: 6508090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating patients with glaucoma from glaucoma suspects and normal subjects by nerve fiber layer assessment with scanning laser polarimetry.
    Choplin NT; Lundy DC; Dreher AW
    Ophthalmology; 1998 Nov; 105(11):2068-76. PubMed ID: 9818608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Absolute filling defects of the optic disc in fluorescein angiograms in glaucoma--a retrospective clinical study].
    Plange N; Remky A; Arend O
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):214-21. PubMed ID: 11392265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.